The one test that can prevent your risk of Cancer, according to top doctor and longevity expert

The detection of cancer at its initial stages becomes essential for survival, because the disease typically reveals itself only after reaching an advanced stage. However, a diagnostic test exists. which detects cancer before any symptoms emerge. The Galleri multi-cancer early detection test provides family cancer patients with a valuable screening method, to identify various cancer types simultaneously which leads to better treatment results, and longer survival rates. Dr. Vass, M.D. tells us why the Galleri multi-cancer test can literally save your life!

What is the Galleri test

The Galleri blood test identifies more than 50 cancer types, by detecting tumor DNA fragments which appear in blood as cell-free DNA. The test uses artificial intelligence to detect cancer-specific chemical methylation signatures, which enable precise cancer location identification at a rate of 92%. The test results in more focused and time-efficient diagnostic procedures for patients. The test functions as a supplementary tool to standard cancer screening methods including mammograms, pap smears and colonoscopies.




Why early detection matters

The treatment success rate for cancer patients improves when doctors detect the disease during its initial stages, because symptoms emerge only when cancer reaches an advanced stage. The Galleri test identifies cancer at its initial stage in more than half of all detected cases (clinical trials showed early-stage cancer detection rates exceeding 50%). The discovery of cancer at an early stage enables medical professionals to initiate treatment procedures which minimize patient death rates. The PATHFINDER 2 study demonstrated that Galleri screening, increased cancer detection by more than seven times when used with standard cancer tests which led to the identification of pancreatic, liver, ovarian, bladder and stomach cancers without screening recommendations.

How effective is the Galleri test

The Galleri test demonstrates 99.6% specificity which results in a 0.4% false-positive rate, that minimizes the need for additional medical tests. The positive predictive value of the test reaches 61.6% which means that 61.6% of people testing positive, will receive a cancer diagnosis. The test revealed cancer indicators in 0.93% of participants during research while confirming cancer in 0.57% of cases. The test detects cancers that standard screening methods fail to identify, which makes it an essential tool for early cancer detection and ongoing monitoring.

Who should consider this test

People who have cancer in their family history, should make Galleri and other MCED tests their top priority. Traditional cancer screening methods only check for a limited number of cancer types, but many cancers develop because of inherited genetic factors. The test enables patients to screen for various cancer types at once, which helps identify cancers that standard screening methods cannot detect. The test provides excellent benefits to people aged 50 and above, and those with additional risk factors who want to monitor their health actively. Patients need to consult their healthcare provider before adding this test to their cancer prevention strategy. The Galleri test functions as an additional screening tool, but patients should follow established screening recommendations.

Limitations and future outlook

The Galleri test represents a breakthrough in medical science, although users need to understand its restricted capabilities. The test has not received complete approval from all regulatory organisations, and it does not guarantee complete cancer detection for all types and stages. Patients who receive positive test results need to undergo additional diagnostic procedures, which might include imaging tests and tissue sample examinations. The test continues to show promise through ongoing research, which aims to enhance its precision and medical benefits. The accumulation of additional research data will lead to worldwide cancer screening transformations which will enable doctors to detect diseases at earlier stages for better treatment results.

Disclaimer: This article is informational only and not a substitute for medical advice

Get an chance to win ₹5000 Amazon Voucher by taking part in India's Biggest Habit Index! Take the survey here